Assessment of the markers of platelet and coagulation activation following transcatheter closure of atrial septal defects-Reference-Cited by-同舟云学术

Assessment of the markers of platelet and coagulation activation following transcatheter closure of atrial septal defects

Published:2005-01 Issue:1 Volume:98 Page:107-112
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Rodés-Cabau Josep,Palacios Andrés,Palacio Carles,Girona Josep,Galve Enrique,Evangelista Arturo,Casaldáliga Jaume,Albert Dipma,Picó Marta,Soler-Soler Jordi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. Percutaneous catheter closure of secundum atrial septal defects: a review;Ebeid;J. Invasive Cardiol.,2002

2. Early and late complications associated with transcatheter occlusion of secundum atrial defect;Chessa;J. Am. Coll. Cardiol.,2002

3. Transcatheter closure as standard treatment for most interatrial defects: experience in 200 patients treated with the Amplatzer Septal Occluder;Berger;Cardiol. Young,1999

4. Percutaneous closure with Amplatzer device is a safe and efficient alternative to surgery in adults with large atrial septal defects;Losay;Am. Heart J.,2001

5. Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience;Chan;Heart,1999

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Right disc thrombosis of the new Gore Cardioform ASD Occluder;Catheterization and Cardiovascular Interventions;2024-03-07

2. The investigation of thrombocytopenia after transcatheter occlusion of patent ductus arteriosus;BMC Cardiovascular Disorders;2024-01-18

3. Case report: Early thrombosis in left atrial during transcatheter closure of ASD in a child with favorable outcome after use of GPIIb/IIIa receptor antagonist and heparin;Frontiers in Pediatrics;2023-03-13

4. Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management;Journal of Clinical Medicine;2023-03-01

5. Hemostatic biomarkers and antithrombotic strategy in percutaneous left atrial interventions: State-of-the-art review;Thrombosis Research;2022-07